Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans...

The Collaborative Research Network (CRN) is a global community of teams working together to spark new discoveries in Parkinson’s disease (PD) research.

Stanford Medicine-led research in mice indicates that inhibiting the LRRK2 enzyme could stabilize patients with a type of Parkinson’s disease.

Statement on the impact and safety of vaccines led by the American Association of Immunologists and the American College of Physicians.

The postwar compact on research that powered America’s economic and military dominance is under threat.

Mutations in LRRK2 and GBA1 are the most common genetic causes of familial Parkinsons disease. Previously, we showed that pathogenic LRRK2 mutations inhibit primary cilia formation in rare interneuron...